The global bioburden testing market size was valued at USD 1.2 billion in 2024 and is projected to grow from USD 1.35 billion in 2025 to USD 2.8 billion in 2033, exhibiting a CAGR of 8.5% during the forecast period (2025–2033).   This report provides an in-depth overview of opportunities across specific segments within the global...